Please login to the form below

Not currently logged in
Email:
Password:

President Trump

This page shows the latest President Trump news and features for those working in and with pharma, biotech and healthcare.

End to middlemen rebates a major shift in US drug pricing

End to middlemen rebates a major shift in US drug pricing

Puts onus on pharma, which cites rebates as biggest barrier. The Trump administration plans to ban rebates paid by pharma to insurance middlemen, and instead wants to see them passed directly ... The changes fulfil promises made by President Trump last

Latest news

  • Rising economic risk casts shadow on Davos meeting Rising economic risk casts shadow on Davos meeting

    That list includes US president Donald Trump who said the government shutdown prevented him and the entire US delegation from attending, as well as UK prime minister Theresa May who is ... Brazil's new right-wing president Jair Bolsonaro. Other absentees

  • FDA moves into crisis mode as shutdown drags on FDA moves into crisis mode as shutdown drags on

    The drastic measures come as Republican and Democrats are trading blows in the shutdown blame game, and President Trump looking increasingly culpable in the public’s eyes as he sticks to ... A last-ditch attempt by Republican senator Lindsey

  • US government shutdown leaves FDA running on empty US government shutdown leaves FDA running on empty

    The agency is essentially operating on reserves from user fees received in the last financial year because the shutdown – brought about by an impasse between President Donald Trump and senior Democrats ... by an impasse between a Democratic President

  • EMA sees approval numbers rise in 2018 EMA sees approval numbers rise in 2018

    the US government shutdown, resulting from President Trump’s demands for money to build a border wall being blocked by Congress.

  • Drug pricing is pharma’s top concern in 2019 Drug pricing is pharma’s top concern in 2019

    report. The number of increases is down from 400 a year ago, according to data provider Rx Savings Solutions, but still fly in the face of pressure from US president Donald ... Trump to forego price hikes as part of a drive to lower the overall cost of

More from news
Approximately 3 fully matching, plus 47 partially matching documents found.

Latest Intelligence

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    Current global president, worldwide research and development and medical, Mikael Dolsten, will also become chief medical officer. ... This was because Read had agreed to reverse previously announced price increases after being telephoned by President

  • Change in the pharma industry is inevitable Change in the pharma industry is inevitable

    Its highly fragmented nature leaves it ripe for further M&A activity - led by emboldened and cash-rich US firms if President Trump, via a low ‘repatriation tax’, opens the door ... And then there is the problem of public opinion. “We have a

  • Focus on the fundamentals Focus on the fundamentals

    Brexit, Trump becoming president and in France a movement that did not exist two years ago holding the parliamentary majority.

  • Pharma deals continue to slide Pharma deals continue to slide

    With the dysfunctional political system in the US it is hardly surprising that eight months following President Trump’s inauguration, the repeal of Obamacare has been dropped and the pricing and ... Similarly, the Euro is now around 10% stronger

  • US health reforms US health reforms

    One of the things I think industry is worried about is if Congress and the President can’t get a health bill passed, do they turn to drug pricing because that ... added. President Trump himself has frequently called for lower drug prices. “Once

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....
Cell and gene therapy
Tackling the manufacturing cost and complexity challenges...

Infographics